Evidence method
Level · gp.fundamentals.capex_revenue_ratio
5.25% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
BGLC · Sep 30, 2023
BioNexus Gene Lab Corp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001477932-24-001468General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-35.22% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-0.83% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
43.38% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
13.88% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-99.01% · CORE · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History29 statesSelf-history eligible
Sep 30, 20214/6 normalizedLevel 3Dec 31, 20214/6 normalizedLevel 3Mar 31, 20225/6 normalizedLevel 3Jun 30, 20225/6 normalizedLevel 3Sep 30, 20226/6 normalizedLevel 3Dec 31, 20226/6 normalizedLevel 3Mar 31, 20236/6 normalizedLevel 3Jun 30, 20236/6 normalizedLevel 3Sep 30, 20236/6 normalizedAmended as filedDec 31, 20236/6 normalizedLevel 3Mar 31, 20245/5 normalizedLevel 3Jun 30, 20245/5 normalizedLevel 3Sep 30, 20245/5 normalizedLevel 3Dec 31, 20246/8 normalizedLevel 3Mar 31, 20256/7 normalizedLevel 3Jun 30, 20256/7 normalizedLevel 3Sep 30, 20256/7 normalizedLevel 3Dec 31, 20256/9 normalizedLevel 3Mar 31, 20266/7 normalizedLevel 3Jun 30, 20266/7 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 0.56%
- Current
- 5.25%
- Delta
- 4.69%
- Previous
- -0.86%
- Current
- -35.22%
- Delta
- -34.36%
- Previous
- 3.29%
- Current
- -0.83%
- Delta
- -4.12%
- Previous
- 45.42%
- Current
- 43.38%
- Delta
- -2.03%
- Previous
- 13.23%
- Current
- 13.88%
- Delta
- 0.64%
- Previous
- -10.60%
- Current
- -99.01%
- Delta
- -88.41%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · BGLC Fundamental State →Analogous To · BGLC state analogue 5 →Transitioned To · BGLC Fundamental State →Transitioned To · BGLC CAPEX_INTENSITY_INCREASED →Transitioned To · BGLC CASH_GENERATION_DECREASED →Transitioned To · BGLC GROWTH_DECREASED →Transitioned To · BGLC INVENTORY_PRESSURE_DECREASED →Transitioned To · BGLC MARGIN_INCREASED →Transitioned To · BGLC PROFITABILITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.